Drug interactions between Miradon and Prozac

Results for the following 2 drugs:
Miradon (anisindione)
Prozac (fluoxetine)

Interactions between your selected drugs

fluoxetine ↔ anisindione

Applies to:Prozac (fluoxetine) and Miradon (anisindione)

MONITOR: Several case reports, including one report of cerebral hemorrhage, suggest that fluoxetine may increase the anticoagulant effects of warfarin. Postulated mechanisms include displacement of warfarin from plasma protein-binding sites, inhibition of the CYP450 2C9 hepatic metabolism of warfarin by fluoxetine, and direct inhibitory effect of fluoxetine on hemostasis. Animal studies have also suggested that fluoxetine (given in very high doses) may increase prothrombin time in animals treated with warfarin. Two small studies of human volunteers, however, found no alteration in the prothrombin time in individuals treated with fluoxetine and warfarin. It is not known if other oral anticoagulants interact with fluoxetine in a similar manner.

MANAGEMENT: Close clinical and laboratory monitoring for altered anticoagulant effect is recommended if oral anticoagulants and fluoxetine must be used together. Patients should be advised to promptly report any signs of bleeding to their physician, including pain, swelling, headache, dizziness, weakness, prolonged bleeding from cuts, increased menstrual flow, vaginal bleeding, nosebleeds, bleeding of gums from brushing, unusual bleeding or bruising, red or brown urine, or red or black stools.

See also...

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.

Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.

Do not stop taking any medications without consulting your healthcare provider.


Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2012 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Advertisement
Close

Recommended

(web3)